AI models need more data about biology, and OpenAI is paying to create it
Last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies.
Brief by WorldPing · Original reporting by MIT Tech Review
WorldPing



